Advertisement

Topics

Aspirin’s benefit in primary CVD prevention countered by bleeding risks

16:44 EST 23 Jan 2019 | Cardiovascular Business

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

Original Article: Aspirin’s benefit in primary CVD prevention countered by bleeding risks

NEXT ARTICLE

More From BioPortfolio on "Aspirin’s benefit in primary CVD prevention countered by bleeding risks"

Advertisement
Quick Search
Advertisement
Advertisement